Effectiveness and limits of antimicrobial treatment on seminal leukocyte concentration and related reactive oxygen species production in patients with male accessory gland infection.
To evaluate whether bacteriological cure, sperm outcome, spontaneous pregnancy rate and white blood cell (WBC)-related reactive oxygen species (ROS) production were related to the extent of the infection and to an intermittent and repetitive antimicrobial treatment, 122 patients with bacterial [>10(5) colony-forming units (CFU)/ml] male accessory gland infections (MAGI) were studied. According to ultrasound criteria, patients had prostatitis (PR, n = 52), prostatovesiculitis (PV, n = 32) or prostatovesiculoepididymitis (PVE, n = 38). Each group was further subdivided into two subsets: one subset (PR, n = 40; PV, n = 20; PVE, n = 25) was given ofloxacin or doxycycline for 14 consecutive days per month for 3 months; the other subset (PR, n = 12; PV, n = 12; PVE, n = 13) received no treatment. The female partners were also treated. All patients were evaluated before, during (1 and 3 months) and after (3 months) treatment. The bacteriological cure rate was the highest (92.5%) after the third antibiotic course in PR, followed by PV (70.4%), and the lowest in PVE (52.0%). At 3 months after therapy discontinuation, some sperm parameters, seminal WBC concentration and ROS generation (assessed in the 45% Percoll fraction) were ameliorated in PR and PV, whereas no improvement occurred in patients with PVE, except for the percentage of coiled tails. Antibiotic treatment in PR and PV patients led to positive effects on sperm output and spontaneous pregnancy rate (40%) by removing pro-oxidant noxae (microbial and/or WBC-related ROS production). The persistent infertility, dyspermia and sperm-derived ROS overproduction in PVE may relate to a significant percentage of antibiotic-independent re-infection and/or to low antioxidative epididymal properties, which persisted following antimicrobial treatment.
Vicari
E
E
Andrology Centre, Department of Internal Medicine, University of Catania, Via A.Diaz 15, 95125 Catania, Italy.
D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000890:Anti-Infective Agents / Q000627:therapeutic use; D001424:Bacterial Infections / Q000188:drug therapy*; D004318:Doxycycline / Q000009:adverse effects / Q000627:therapeutic use; D004823:Epididymitis / Q000150:complications / Q000000981:diagnostic imaging / Q000382:microbiology; D005260:Female; D005832:Genital Diseases, Male / Q000382:microbiology*; D006801:Humans; D007248:Infertility, Male / Q000382:microbiology*; D007958:Leukocyte Count; D008297:Male; D015242:Ofloxacin / Q000009:adverse effects / Q000627:therapeutic use; D011247:Pregnancy; D011472:Prostatitis / Q000150:complications / Q000000981:diagnostic imaging / Q000382:microbiology; D017382:Reactive Oxygen Species / Q000378:metabolism; D012661:Semen / Q000166:cytology*; D012669:Seminal Vesicles; D013091:Spermatogenesis; D013094:Spermatozoa / Q000002:abnormalities / Q000502:physiology; D016896:Treatment Outcome; D014463:Ultrasonography
D000900:Anti-Bacterial Agents; D000890:Anti-Infective Agents; D017382:Reactive Oxygen Species; D015242:Ofloxacin; D004318:Doxycycline